share_log

Invitation to the Presentation of Calliditas ́s Interim Report January - March 2024

Invitation to the Presentation of Calliditas ́s Interim Report January - March 2024

邀請參加2024年1月至3月Calliditas中期報告的發佈會
PR Newswire ·  05/16 02:43

STOCKHOLM, May 16, 2024 /PRNewswire/ -- Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET.

斯德哥爾摩,2024 年 5 月 16 日 /PRNewswire/-- Calliditas的2024年1月至3月第一季度中期報告將於歐洲中部時間2024年5月23日星期四上午7點以瑞典語和英語發佈。

A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.

歐洲中部時間當天下午 14:30 將舉行一次有機會提問的音頻和電話會議,首席執行官蕾妮·阿吉亞爾-盧坎德和首席財務官弗雷德裏克·約翰遜、首席營銷官理查德·菲利普森和北美總裁瑪麗亞·託恩森。

The presentation will be given in English.

演講將以英文進行。

Link to the webcast:

鏈接到網絡直播:

Calliditas Therapeutics Q1 Report 2024 (financialhearings.com)

Calliditas Therapeutics 2024 年第一季度報告(financialhearings.com)

To participate via conference call please register via this link:

要通過電話會議參加,請通過以下鏈接註冊:

After registration, you will receive a phone number and a conference ID to log in to the conference call. Via the telephone conference, there is an opportunity to ask oral questions.

註冊後,您將收到一個電話號碼和一個會議 ID,用於登錄電話會議。通過電話會議,有機會提出口頭問題。

For further information, please contact:

欲了解更多信息,請聯繫:

Åsa Hillsten, Head of IR & Sustainability, Calliditas

Asa Hillsten,Calliditas 投資者關係與可持續發展主管

Tel. +46 76 403 35 43, Email: [email protected]

電話:+46 76 403 35 43,電子郵件:[email protected]

The information was sent for publication, through the agency of the contact person set out above, on 16 May, 2024, at 8:30 a.m. CET.

該信息已於歐洲中部時間2024年5月16日上午 8:30 通過上述聯繫人的代理機構發送出版。

This information was brought to you by Cision

這些信息是由 Cision 帶給你的

The following files are available for download:

以下文件可供下載:

Invitation to the presentation of Calliditas_Q1 2024

邀請參加 Calliditas_Q1 2024 演講

SOURCE Calliditas Therapeutics

來源 Calliditas 療法

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論